Daniela Pollutri
Bologna, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
miR-6850 drives phenotypic changes and signaling in high grade serous ovarian cancer.
Journal: Non-coding RNA research
Published: July 30, 2025
Ribosomal protein L5 (RPL5/uL18) I60V mutation is associated to increased translation and modulates drug sensitivity in T-cell acute lymphoblastic leukemia cells.
Journal: Biochemical pharmacology
Published: July 28, 2025
Master of disguise: ribosomal protein L5 beyond translation.
Journal: Biochimie
Published: December 12, 2024
Ataluren improves myelopoiesis and neutrophil chemotaxis by restoring ribosome biogenesis and reducing p53 levels in Shwachman-Diamond syndrome cells.
Journal: British journal of haematology
Published: March 23, 2023
Mutational analysis of ribosomal proteins in a cohort of pediatric patients with T-cell acute lymphoblastic leukemia reveals Q123R, a novel mutation in RPL10.
Journal: Frontiers in genetics
Published: September 30, 2022
Involvement of miR-30a-5p and miR-30d in Endothelial to Mesenchymal Transition and Early Osteogenic Commitment under Inflammatory Stress in HUVEC.
Journal: Biomolecules
Published: December 29, 2020
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma.
Journal: Journal of clinical medicine
Published: December 17, 2018
The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma.
Journal: Cell death & disease
Published: June 14, 2017
TP53/MicroRNA Interplay in Hepatocellular Carcinoma.
Journal: International journal of molecular sciences
Published: October 13, 2016
In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3-Mediated Apoptosis.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 09, 2016
Last Updated: 09/26/2026